Dr. Daniel DeMarco Weighs In on New Therapy Discussion

Daniel DeMarco, M.D., Digestive Health Associates of Texas (DHAT), an affiliated partner with AmSurg and director of digestive disease technology at the Baylor Health Care System in Texas, weighed in on the Food and Drug Administration’s decision to require doctors to apply for permission to deploy fecal transplantation for therapeutic use calling it an “investigational new drug.” DeMarco said his institution stopped doing fecal transplants late last year when it became aware the FDA was looking into it. DeMarco said he was disappointed when he had to stop but understood the FDA’s concerns. He had used the therapy with five patients, and four overcame C. diff, he said.”

Full Story